|

Development of a FibroScan Liver Examination Using a Single Probe

RECRUITINGN/ASponsored by Echosens
Actively Recruiting
PhaseN/A
SponsorEchosens
Started2025-11-14
Est. completion2026-11-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07400289

Summary

This is an exploratory, international, prospective, interventional, multicenter clinical investigation that will take place in 1 Hong Kong site and 3 French sites and 309 adults patients will be included. The study objective is to assess the LSM reproducibility between the FibroScan examination performed with the Single Probe (SP) and the FibroScan examination performed with the reference probes (M and XL).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adult patients (≥ 18 years of age).
* Patient followed with a chronic liver disease.
* Adult patient able to give his written consent.
* For European sites: patient affiliated to the healthcare system.

Exclusion Criteria:

* Vulnerable patients.
* Patients with ascites.
* Patients with heart failure.
* Patients with acute hepatitis.
* Patients with biliary obstruction.

Conditions2

Liver DiseaseLiver Diseases

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.